Mechanisms of Pro-Inflammatory Diseases
joint with Innate Immunity and Determinants of Microbial Pathogenesis
Organizer(s): Virginia Pascual, Mark S. Anderson and Daniel KastnerDate: April 19 - 24, 2015
Location: Resort at Squaw Creek, Olympic Valley, CA, USA
Inflammation is a physiological process that repairs tissues in response to harmful endogenous or exogenous stimuli and involves the movement of plasma and leukocytes to the injured site. While acute inflammatory responses are generally protective, chronic states of inflammation have detrimental consequences and lead to tissue destruction and disease. Indeed, chronic inflammatory diseases, such as MS, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, and diabetes are major clinical problems today. This meeting brings together clinical and basic scientists interested in inflammation and translational research with a view to understanding basic mechanisms of inflammation and identifying novel approaches for therapeutic intervention, leveraging recent advances in basic immunology, genomics and systems biology. A particular emphasis is on human autoimmune and autoinflammatory diseases. Opportunities for interdisciplinary interactions are significantly enhanced by the concurrent meeting on 'Innate Immunity and Determinants of Microbial Pathogenesis,' which shares a keynote address and three plenary sessions with this meeting.
Scholarship Deadline: December 18 2014
Discounted Abstract Deadline: December 18 2014
Abstract Deadline: January 21 2015
Discounted Registration Deadline: February 19 2015
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Novartis Institutes for BioMedical Research
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI115820-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.